Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 85.96% is in line with its 5-year average of 83.59%, near the high end of its 5-year range (76.12%–85.96%).
As of the fiscal period ended Tuesday, March 31, 2026. 4.90% above its 12-month average of 81.94%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
85.96%
GROSS MARGIN AVG TTM
81.94%
GROSS MARGIN AVG 3Y
84.53%
GROSS MARGIN AVG 5Y
83.97%
GROSS MARGIN AVG 10Y
84.08%
GROSS MARGIN AVG 15Y
83.80%
GROSS MARGIN AVG 20Y
82.29%
CURRENT VS TTM AVG
+4.90%
CURRENT VS 3Y AVG
+1.68%
CURRENT VS 5Y AVG
+2.37%
CURRENT VS 10Y AVG
+2.23%
CURRENT VS 15Y AVG
+2.57%
CURRENT VS 20Y AVG
+4.45%
SECTOR MEDIAN · HEALTHCARE
58.69%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+46.46%
vs the sector median at left
Market Cap
$182.83B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
Market Cap
$214.73B
Gross Margin
40.37%
TTM Avg
39.50%
3Y Avg
40.36%
5Y Avg
43.54%
Market Cap
$163.59B
Gross Margin
79.59%
TTM Avg
78.55%
3Y Avg
78.10%
5Y Avg
78.28%
Market Cap
$140.36B
Gross Margin
58.51%
TTM Avg
60.22%
3Y Avg
59.98%
5Y Avg
59.48%
Market Cap
$132.55B
Gross Margin
66.68%
TTM Avg
66.73%
3Y Avg
66.82%
5Y Avg
67.04%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $197.66B | 85.96% | 81.94% | 84.53% | 83.97% |
| Abbott Laboratories (ABT)vs › | $182.83B | 56.80% | 53.17% | 51.86% | 51.92% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $214.73B | 40.37% | 39.50% | 40.36% | 43.54% |
| Amgen Inc. (AMGN)vs › | $220.11B | 72.65% | 66.16% | 69.53% | 71.51% |
| Gilead Sciences, Inc. (GILD)vs › | $163.59B | 79.59% | 78.55% | 78.10% | 78.28% |
| Pfizer Inc. (PFE)vs › | $147.10B | 71.32% | 68.05% | 62.23% | 63.06% |
| AstraZeneca PLC (AZN)vs › | $250.47B | 81.88% | 81.51% | 79.26% | 77.31% |
| Danaher Corporation (DHR)vs › | $140.36B | 58.51% | 60.22% | 59.98% | 59.48% |
| Intuitive Surgical, Inc. (ISRG)vs › | $132.55B | 66.68% | 66.73% | 66.82% | 67.04% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.98B | 70.16% | 62.23% | 59.55% | 57.82% |
Gross Margin
86.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 85.96% |
| 2025-12-31 | 80.86% |
| 2025-09-30 | 76.12% |
| 2025-06-30 | 83.29% |
| 2025-03-31 | 83.49% |
| 2024-12-31 | 84.80% |
| 2024-09-30 | 84.14% |
| 2024-06-30 | 84.90% |
| 2024-03-31 | 84.83% |
| 2023-12-31 | 84.80% |
| 2023-09-30 | 83.46% |
| 2023-06-30 | 85.53% |
| 2023-03-31 | 84.67% |
| 2022-12-31 | 82.82% |
| 2022-09-30 | 84.20% |
| 2022-06-30 | 85.29% |
| 2022-03-31 | 83.54% |
| 2021-12-31 | 83.72% |
| 2021-09-30 | 82.99% |
| 2021-06-30 | 83.21% |
| 2021-03-31 | 82.81% |
| 2020-12-31 | 82.52% |
| 2020-09-30 | 83.33% |
| 2020-06-30 | 84.10% |
| 2020-03-31 | 84.10% |
| 2019-12-31 | 83.24% |
| 2019-09-30 | 83.24% |
| 2019-06-30 | 83.86% |
| 2019-03-31 | 83.84% |
| 2018-12-31 | 84.35% |
| 2018-09-30 | 84.10% |
| 2018-06-30 | 84.12% |
| 2018-03-31 | 84.42% |
| 2017-12-31 | 83.21% |
| 2017-09-30 | 83.95% |
| 2017-06-30 | 84.60% |
| 2017-03-31 | 85.06% |
| 2016-12-31 | 83.37% |
| 2016-09-30 | 85.52% |
| 2016-06-30 | 85.27% |
| 2016-03-31 | 84.44% |
| 2015-12-31 | 84.04% |
| 2015-09-30 | 85.64% |
| 2015-06-30 | 85.74% |
| 2015-03-31 | 84.63% |
| 2014-12-31 | 83.73% |
| 2014-09-30 | 84.60% |
| 2014-06-30 | 83.03% |
| 2014-03-31 | 82.96% |
| 2013-12-31 | 84.33% |
| 2013-09-30 | 82.81% |
| 2013-06-30 | 83.13% |
| 2013-03-31 | 81.94% |
| 2012-12-31 | 84.96% |
| 2012-09-30 | 82.44% |
| 2012-06-30 | 82.41% |
| 2012-03-31 | 80.83% |
| 2011-12-31 | 82.77% |
| 2011-09-30 | 80.34% |
| 2011-06-30 | 80.63% |
| 2011-03-31 | 80.14% |
| 2010-12-31 | 80.87% |
| 2010-09-30 | 81.16% |
| 2010-06-30 | 80.71% |
| 2010-03-31 | 80.33% |
| 2009-12-31 | 79.83% |
| 2009-09-30 | 78.55% |
| 2009-06-30 | 79.92% |
| 2009-03-31 | 79.93% |
| 2008-12-31 | 79.85% |
| 2008-09-30 | 76.83% |
| 2008-06-30 | 77.01% |
| 2008-03-31 | 77.27% |
| 2007-12-31 | 76.29% |
| 2007-09-30 | 76.07% |
| 2007-06-30 | 77.67% |
| 2007-03-31 | 76.35% |
| 2006-12-31 | 75.35% |
| 2006-09-30 | 75.58% |
| 2006-06-30 | 76.84% |
| 2006-03-31 | 73.04% |
| 2005-12-31 | 73.22% |
| 2005-09-30 | 73.18% |
| 2005-06-30 | 73.36% |
| 2005-03-31 | 71.28% |
| 2004-12-31 | 72.14% |
| 2004-09-30 | 71.76% |
| 2004-06-30 | 72.87% |
| 2004-03-31 | 71.85% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
| 2002-06-30 | 0.00% |
